Columbia Care Releases Preliminary Results for First Quarter 2019 and Full Year 2018

Organic growth continues to drive revenue increases of 45% for Q1 2019 and 35% for FY 2018 on year-over-year basis Closing of go-public transaction to accelerate strategy execution and long-term growth prospects NEW YORK–(BUSINESS WIRE)– Columbia Care Inc. (“Columbia Care”, or the “Company”) (NEO: CCHW), today announced preliminary revenue and gross profit results for the Read More

Columbia Care Launches “100,000,000 Ways to Break the Opioid Crisis” Initiative

Columbia Care to partner with experts at Montefiore Medical Center and Albert Einstein College of Medicine for initial phase of nationwide study on medical cannabis’s impact on opioid use for pain NEW YORK–(BUSINESS WIRE)– Columbia Care Inc. (“Columbia Care”, or the “Company”) (NEO: CCHW), a leading international medical cannabis company, today announced the launch of Read More

Columbia Care Releases Preliminary Results for First Quarter 2019 and Full Year 2018

Organic growth continues to drive revenue increases of 45% for Q1 2019 and 35% for FY 2018 on year-over-year basis Closing of go-public transaction to accelerate strategy execution and long-term growth prospects NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (“Columbia Care”, or the “Company”) (NEO: CCHW), today announced preliminary revenue and gross profit results for the quarter Read More

Columbia Care Announces Peer-Reviewed Publication in Collaboration with New York University Detailing Medical Cannabis Use Among Cancer and Non-Cancer Patients

NEW YORK, March 26, 2019 — Columbia Care Inc., one of the nation’s leading medical cannabis companies, today announced the peer-reviewed publication of research in collaboration with New York University (NYU) Department of Medicine and Rehabilitation Medicine demonstrating key differences in demographics and medical cannabis product use between patients with cancer and without cancer in Read More

Columbia Care Selected by the New Jersey Department of Health to Cultivate, Process and Dispense Medical Cannabis Products

One of six companies awarded fully integrated license out of 146 applicants New Jersey will be the 14th state where Columbia Care is licensed to operate NEW YORK, Dec. 18, 2018 – Columbia Care Inc. (“Columbia Care”), one of the nation’s leading medical cannabis companies, today announced that, after a rigorous vetting and selection process, Read More

Columbia Care Further Expands Pennsylvania Presence with Opening of Dispensary in Allentown

NEW YORK, Dec. 13, 2018 – Columbia Care Inc. (“Columbia Care”), the nation’s largest and most experienced medical cannabis company, announces the opening of an additional medical cannabis dispensary in Pennsylvania. The new dispensary, located at 3025 W. Tilghman Street in Allentown, will begin serving qualifying patients on Dec. 17, 2018. The location is Columbia Read More

Columbia Care Continues to Expand Presence in Pennsylvania with Opening of Dispensary in Wilkes-Barre

NEW YORK, Dec. 03, 2018 — Columbia Care Inc. (“Columbia Care”), the nation’s leading medical cannabis company, announces the opening of an additional medical cannabis dispensary in Pennsylvania. The new dispensary, located at 765 Kidder Street in Wilkes-Barre, opened today, December 3, 2018. The location is Columbia Care’s second dispensary serving qualifying patients in Pennsylvania, Read More

Columbia Care Leads US Cannabis Industry Towards Global Expansion By Becoming First American Company Licensed in European Union

Launches EU and global expansion strategy with fully integrated license issued by federal government of Malta NEW YORK – Nov. 15, 2018 – Columbia Care Inc., the leading medical cannabis company in the United States (U.S.), announced today that it received notification that its application for licensure in Malta has been approved by Malta Enterprise, Read More

Columbia Care and The Center for Discovery to Collaborate on Study Examining the Use of Cannabis-Derived Medicines in Treating Epilepsy

Research to be led by neurologist Orrin Devinsky, M.D., director of NYU Langone’s Comprehensive Epilepsy Center and world leader in the study of epilepsy, and Dr. Terry Hamlin, associate executive director of The Center for Discovery, renowned for complex care Study will investigate the optimal dose of Columbia Care’s ClaraCeed™ and ClaraCeed Ultra™ cannabis-derived tablets Read More

Columbia Care Secures Good Manufacturing Practice (GMP) Certification for Medical Cannabis Manufacturing Facility in Florida

Columbia Care Florida achieves GMP certification, reinforcing its commitment to quality and safety in medical cannabis manufacturing Manufacturing facility reports record tolerance specifications of less than 1% active pharmaceutical ingredient (API) variability across initial production batches ARCADIA, FL – Nov. 6, 2018 – Columbia Care Inc., the nation’s leading medical cannabis company, today announced that Read More

1 2 3 4